Prittle Prattle Pr

Category: Health

  • MGM Healthcare Uses Surgical Precision to Treat Rare Cyst Found in Brain Tissue

    Dr V. R. Roopesh Kumar, Director of Neurosurgery at MGM Healthcare, and Mr Nilesh Mundada, COO, MGM Healthcare and Senior Vice President, Finance, MGM Group, said precise diagnosis and complete microsurgical removal were critical in treating a condition reported in only around 45 cases worldwide.

    MGM Healthcare has treated an exceptionally rare case involving a cyst with gastric characteristics located in the brain, a condition reported in only around 45 cases worldwide.
    The patient, a young IT professional, had presented with weakness in the limbs. The hospital’s medical team identified the condition accurately and carried out a craniotomy with microsurgical removal of the cyst. The procedure required careful handling to prevent any spillage of the cyst contents into the brain.

    According to the hospital, the cyst contained acidic fluid with high levels of Amylase. Any release of this fluid into surrounding brain tissue could have caused damage and led to complications including severe seizures.
    The case was led by Dr V. R. Roopesh Kumar, Director of Neurosurgery, MGM Healthcare, who had encountered a similar rare case nearly two decades ago. That earlier experience proved important when the cyst revealed a light yellow fluid, unlike the clear and colourless Cerebrospinal fluid usually associated with more common brain cysts.

    MGM Healthcare said that if the condition had not been diagnosed correctly, the likely approach would have been to drain the fluid and leave the cyst behind. That could have resulted in long term damage to the brain. After surgery, the patient recovered well and normal function in the limbs was restored.
    Dr V. R. Roopesh Kumar said, “What we found in the brain was an enterogenous cyst, that is a cyst lined by tissue similar to the gastrointestinal tract, containing stomach like lining. The cyst could easily have passed off as a typical brain cyst. However, we were alerted by the light yellow colour of the fluid. Fortunately, I had encountered a similar case nearly twenty years ago, and that experience helped in identifying this condition accurately.”

    He said the medical team analysed the fluid and sent part of the cyst for biopsy. Both confirmed that the condition was not an Arachnoid cyst, which is typically filled with clear and colourless Cerebrospinal fluid surrounding the brain and spinal cord.
    Dr Kumar also said such rare conditions can be linked to developmental anomalies. During early development, the spine and intestine lie close to each other and usually separate as development continues. In some cases, remnants may remain within neural tissues, most often in the spine or lower part of the cranium. Their presence in the upper compartment is extremely rare, which was the case here.
    Mr Nilesh Mundada, COO, MGM Healthcare and Senior Vice President, Finance, MGM Group, said, “This case underscores the critical importance of precise diagnosis backed by deep clinical expertise. The ability of our team to identify a rare enterogenous cyst, something that could easily have been mistaken for a routine brain cyst, highlights the strength of multidisciplinary evaluation at MGM Healthcare.”
    He added that complete removal of the cyst without any spillage was equally important in preventing possible damage to the brain. The hospital said the outcome reflects the role of advanced diagnostics and specialist surgical care in managing rare neurological conditions.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • La Polo Marks Fifth Edition of Indian Polo Awards with Strong Industry Presence

    Maninder Sethi, Founder of La Polo, and Preeti Singh, Events and Marketing Head, said the fifth edition highlighted the growing presence of polo across sport, business, and cultural circles.

    La Polo hosted the fifth edition of The Indian Polo Awards in New Delhi, bringing together members of the polo community along with representatives from business, culture, and diplomacy.
    Held at The Taj Palace, the event saw participation from players, patrons, and stakeholders associated with the sport, reflecting its expanding presence and continued relevance in India.

    Among those present were Naveen Jindal, Chairman, Jindal Steel and Member of Parliament, Shallu Jindal, Amanpreet Kaur, IRS, Rajiv Ashok, Managing Director, CCIC, Lt Gen Mukesh Chadha, along with members of the diplomatic and corporate community. Polo players including Arjuna Awardees Samir Suhag and Simran Singh Shergill were also in attendance.
    The awards recognised contributions across the polo ecosystem, including teams, players, trainers, and institutions associated with the sport. Achievers Polo Team received recognition in the high goal category, while Jindal Panther Polo Team featured among winners across categories. Individual honours included Syed Shamsheer Ali as Most Valuable Polo Player and Sawai Padmanabh Singh as Promising Polo Player.

    Other recognitions included Christopher Mackenzie in the international category, Lt Col Vishal Chauhan representing army polo, and Dr Shivangi Jai Singh among the awarded players. Institutional and ecosystem categories covered polo clubs, grounds, trainers, and contributors supporting the sport’s development.
    Maninder Sethi, Founder, La Polo, said, “We are truly overwhelmed by the response to the fifth edition of The Indian Polo Awards. It is encouraging to see the polo fraternity come together alongside leaders from diverse industries to recognise and support the sport.”

    Preeti Singh, Events and Marketing Head, La Polo, said, “This edition reflects strong participation and continued collaboration across partners and the polo community. Their contribution remains important in supporting the sport’s ecosystem.”
    The event was supported by partners including Jindal Polo, Code Silver, Wedding Asia, La Martina, Lexus New Delhi, and U.S. Polo Assn.
    Now in its fifth year, The Indian Polo Awards continues to function as a platform recognising achievements within the sport while bringing together stakeholders connected to its development. The organisers said the initiative aims to support the long term growth and visibility of polo in India.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Gabify Gains Investor Backing to Accelerate Early Screening and Therapy Systems

    Sahil Chopra, Founder and Chief Executive Officer of Gabify, and Ankur Mittal, Co-founder of Inflection Point Ventures, said the funding will support clinical validation, technology development, and wider access to early screening and intervention systems.

    Gabify, a health technology startup focused on neurodevelopmental care, has raised 175000 dollars in a pre seed funding round led by Inflection Point Ventures, with additional support through a government backed grant.
    The company has also received 25 lakh rupees under the Nidhi Seed Support Scheme from GH Raisoni Technology Business Incubator Foundation. The funding will be used for clinical validation, technology enhancement, and team expansion as the company works to scale its platform.

    Founded in 2023, Gabify is building an AI based platform for early screening and therapy management of speech and neurodevelopmental disorders, including autism and ADHD. The system combines voice and vision based AI to analyse speech patterns, facial expressions, eye movement, and behavioural indicators across more than 189 clinically validated parameters aligned with global diagnostic frameworks.
    The platform also uses a human in loop approach, where clinical experts review AI generated outputs to ensure accuracy and reliability in assessments. The company said its system can reduce assessment time by up to 70 percent, allowing clinicians to serve more patients while maintaining clinical standards.

    Ankur Mittal, Co-founder, Inflection Point Ventures, said, “Addressing neurodevelopmental challenges at an early stage plays a critical role in shaping a child’s future, yet it remains one of the most underserved areas in the healthcare ecosystem. Gabify is tackling this gap through a strong blend of clinical validation and AI led innovation, enabling faster and more accurate identification of developmental conditions.”
    Gabify has already tested its platform across more than 35 preschool and daycare centres in India during its private beta phase. It is currently being used by schools, hospitals, private practices, and non profit organisations.

    Sahil Chopra, Founder and Chief Executive Officer, Gabify, said, “Our goal with Gabify is to ensure that no child is left behind simply due to delayed diagnosis or lack of access. We are building technology that supports clinicians, assists parents, and improves early intervention outcomes.”
    The company is part of the fourth cohort of IPV IdeaSchool, a programme focused on early stage startups, and has been recognised among the top 10 startups by DreamDeal, an initiative led by Anupam Mittal.

    Gabify said it aims to impact one million children by 2028 through a mix of business and community focused deployment models, including B2B, B2C, and CSR programmes.
    The broader market opportunity for neurodevelopmental care is estimated at 110 billion dollars globally, supported by rising diagnosis rates, increased adoption of AI in healthcare, and growing demand for early intervention systems.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Gaudium IVF applies artificial intelligence to improve precision in infertility treatment

    Dr Manika Khanna, Chairperson and Managing Director, Gaudium IVF, and Giles Palmer, Director, IVF 2.0, highlight precision led IVF processes and improved clinical decision making

    Mumbai, April 2, 2026: Gaudium IVF has integrated artificial intelligence into infertility treatment, introducing advanced embryology systems into routine clinical practice.
    The development includes the use of AI driven tools such as SiD, a sperm identification system, and ERICA, an embryo ranking platform, aimed at improving precision during key stages of the IVF process.
    The initiative was inaugurated by Nitin Jairam Gadkari, Union Minister for Road Transport and Highways, Government of India, who highlighted the role of advanced technologies in driving innovation across sectors.

    The integration has been undertaken in collaboration with IVF 2.0, a UK based embryology innovation organisation founded by Jacques Cohen and Alejandro Chave, bringing global embryology expertise into the Indian clinical ecosystem.
    Dr Manika Khanna, Chairperson and Managing Director, Gaudium IVF, said, “Fertility care is evolving towards precision led outcomes. The integration of AI allows for greater consistency, transparency, and improved decision making in the treatment process.”

    SiD analyses sperm movement parameters to identify viable candidates for fertilisation, while ERICA evaluates embryo quality using image based analysis of developmental characteristics. These non invasive tools assist embryologists in making more consistent and data driven decisions.
    Giles Palmer, Clinical Scientist and Director of Global Communications, IVF 2.0, said the collaboration enables the application of embryology intelligence in clinical settings, supporting measurable improvements in outcomes.

    Early observations indicate that AI integration can improve fertilisation rates and blastocyst development, while potentially reducing the need for repeat treatment cycles. This may help lower the emotional and financial burden on patients.
    Gaudium IVF, which recently became India’s first publicly listed IVF chain, continues to focus on technology driven approaches in reproductive healthcare, with a growing presence across India.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • AMTZ and Narayan Seva Sansthan Sign Five Year Pact to Localise Advanced Prosthetic Manufacturing

    Palak Agarwal, Director, Narayan Seva Sansthan, says collaboration with Andhra Pradesh MedTech Zone Limited supports Vision 2030 goal of delivering 1 lakh artificial limbs

    Mumbai, February 17, 2026: Andhra Pradesh MedTech Zone Limited, a Government of Andhra Pradesh enterprise, has signed a five year Memorandum of Understanding with Narayan Seva Sansthan to co develop and manufacture affordable prosthetic, orthotic and assistive technologies.
    The agreement brings together AMTZ’s medical technology infrastructure and Narayan Seva Sansthan’s rehabilitation and clinical expertise. The partnership supports the non profit’s Vision 2030 objective of delivering one lakh artificial limbs across India.

    According to Census 2011 data, India has 2.68 crore persons with disabilities. Movement disability accounts for 54.36 lakh individuals, hearing impairment for 50.72 lakh, and visual impairment for 50.33 lakh. Nearly 69.49 percent of persons with disabilities reside in rural areas, underscoring the need for accessible and affordable assistive devices.
    Palak Agarwal, Director, Narayan Seva Sansthan, said, “Through our partnership with AMTZ, we aim to make advanced prosthetics and assistive technologies more affordable and accessible across India. Our goal is to expand mobility and independence while progressing towards our Vision 2030 commitment of reaching one lakh beneficiaries.”

    Currently, a standard artificial limb provided by Narayan Seva Sansthan costs approximately ₹10,000. Advanced above knee prosthetics fitted with pneumatic knee joints and carbon foot components cost about ₹41,000 due to imported inputs. The collaboration seeks to reduce this cost to nearly ₹10,000 through indigenous manufacturing while maintaining performance standards.
    Under the agreement, AMTZ will provide access to research laboratories, prototyping facilities and technical support. Narayan Seva Sansthan will oversee clinical validation, rehabilitation protocols and nationwide assistive device camps. Both organisations will jointly pursue research grants, patent filings and funding opportunities to scale production.

    The partnership covers powered and myoelectric prosthetics, sports and cosmetic limb solutions, orthotic devices including diabetic foot management tools and walking braces, mobility aids such as walkers, wheelchairs and crutches, and advanced hearing devices.
    The five year pact positions indigenous production at the centre of efforts to expand access to performance based prosthetic and assistive technology in India.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • 75 Year Old Undergoes Multi Level Endoscopic Spine Fusion at MGM Healthcare Malar Adyar

    Dr Vignesh Pushparaj, Senior Consultant Orthopaedic Spine Surgeon, MGM Healthcare Malar Adyar, India, says the minimally invasive procedure enabled same day mobilisation; Venugopal Bhat, Chief Operating Officer and Group Vice President Strategic Initiatives, MGM Healthcare, India, highlights focus on advanced spine care

    February 17, 2026: MGM Healthcare Malar Adyar has performed what it describes as the city’s first multi level endoscopic Transforaminal Lumbar Interbody Fusion procedure on a 75 year old patient suffering from severe lower back pain and restricted mobility caused by nerve compression and age related spinal degeneration.
    The surgery involved fusion at two lumbar levels, L3 L4 and L4 L5. The minimally invasive procedure relieved nerve pressure and stabilised the spine by permanently joining the affected vertebrae. The patient was mobilised within hours of surgery and discharged the following day.

    Spinal fusion is performed when a segment of the spine becomes unstable or continues to cause pain despite conservative management such as medication, physiotherapy or injections. By eliminating movement at the affected segment, the procedure reduces mechanical pain and prevents ongoing nerve compression.
    Endoscopic Transforaminal Lumbar Interbody Fusion is carried out through small incisions using specialised instruments. Compared to conventional open surgery, the approach limits muscle disruption, reduces blood loss and lowers the risk of infection, particularly in elderly patients.

    The surgical team was led by Dr Vignesh Pushparaj, Senior Consultant Orthopaedic Spine Surgeon, MGM Healthcare Malar Adyar, India.
    Dr Vignesh Pushparaj said, “The patient presented with severe lower back pain and significant restriction of movement. Imaging confirmed the need for fusion at two levels. Instead of conventional open surgery, we chose a minimally invasive approach. The patient was mobilised on the same day, walked independently and was discharged within 24 hours.”

    He added that traditional open spine surgery involves larger incisions and muscle retraction, which can increase tissue trauma and delay recovery. The endoscopic approach reduces surgical morbidity and supports faster rehabilitation in senior patients.
    Venugopal Bhat, Chief Operating Officer and Group Vice President Strategic Initiatives, MGM Healthcare, India, said, “Performing a complex multi level endoscopic spine fusion in a senior citizen reflects our focus on minimally invasive techniques that prioritise patient safety and recovery.”
    The medical team also advised maintaining correct posture, avoiding prolonged sitting beyond 90 minutes without breaks, and ensuring regular movement to support long term spinal health.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Over 400 Doctors Attend HCG CME in Kolkata on Advancing Precision Cancer Care

    Dr B. S. Ajaikumar, Founder and Chairman of HealthCare Global Enterprises Ltd., calls for disciplined data tracking and evidence based oncology practice

    Kolkata, February 11, 2026: HealthCare Global Enterprises Ltd. hosted a Continuing Medical Education programme in Kolkata titled Decoding the Future of Cancer Care Harnessing Next Generation Intelligence to Transform Patient Outcomes. The session was led by Dr B. S. Ajaikumar, Founder and Chairman, HCG, and attended by more than 400 doctors, including HCG clinicians and senior oncologists and specialists from across the region.
    The programme focused on delivering appropriate treatment at the earliest stage through integration of clinical research, structured data and precision oncology. It included a keynote address by Dr Ajaikumar followed by a panel discussion examining the role of genomics, advanced diagnostics and outcomes measurement systems in shaping cancer treatment pathways.

    Speaking at the CME, Dr B. S. Ajaikumar said, “As oncology continues to evolve in complexity, the responsibility of leadership is to ensure that innovation is applied with clinical rigour and evaluated through outcomes. Delivering the right treatment, the first time, requires disciplined data collection, longitudinal outcome tracking, and evidence-based, multidisciplinary decision-making. Platforms such as this CME enable informed clinical dialogue and collective learning, while reinforcing a research-led, data-driven approach reflected in our peer-reviewed publications and international scientific presentations that strengthens consistent, outcomes-led cancer care for the benefit of patients.”

    During his address, Dr Ajaikumar highlighted the importance of understanding cancer biology, disease progression and treatment response over time in reducing recurrence. He noted that structured research and systematic outcome tracking contribute to refining treatment strategies.
    Discussions during the programme addressed reducing diagnostic delays, optimising therapeutic choices and ensuring evidence based interventions. Sessions covered developments in targeted therapies and immunotherapy, the integration of genomics into routine decision making, emerging disease patterns and the use of advanced diagnostics and AI enabled tools, as well as strengthening outcomes registries.

    Dr Manish Mattoo, CEO and Executive Director, HealthCare Global Enterprises Ltd., said, “The future of oncology lies in building systems that consistently support the right treatment decisions at the right time. At HCG, we are focused on integrating research, data, and technology into care delivery to improve predictability, efficiency, and outcomes across the cancer care continuum. Knowledge-sharing forums such as this CME are critical enablers of that transformation.”
    Dr Rupali Basu, Regional Business Head East and AP, HCG, said, “Eastern and North-Eastern India are witnessing evolving cancer trends and a growing need for advanced, accessible oncology care. Through focused knowledge exchange, clinical collaboration, and future-ready infrastructure, including Outreach Centres, we are working to ensure patients receive high-quality cancer care closer to home.”

    The CME included case based discussions from multidisciplinary care pathways and deliberations on access to advanced testing, inter specialty coordination and clinician training for interpreting complex genomic data. The programme concluded with an interactive session involving specialists from Radiation Oncology, Medical Oncology, Surgical Oncology, General Surgery, General Medicine, Urology, Nephrology, ENT and Maxillofacial Surgery.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Stem cell donor matching access expands for thalassemia families in Vizag

    Dr Deenadayalan Munirathnam of MGM Cancer Institute Chennai, Patrick Paul of DKMS Foundation India and Sarath Babu Voggu of Saptha Foundation detail high resolution HLA testing support for 55 families at King George General Hospital

    Visakhapatnam, 13 February 2026: Access to stem cell donor matching for children diagnosed with thalassemia and sickle cell disease expanded in north coastal Andhra Pradesh through a high resolution HLA testing initiative conducted at King George General Hospital, Visakhapatnam.
    The effort brought together over 55 families from Visakhapatnam, Vizianagaram, Paderu, Srikakulam and Parvathipuram, with more than 200 cheek swab samples collected from patients and family members for advanced HLA typing. The initiative was organised by MGM Cancer Institute, Chennai in collaboration with Saptha Foundation and supported by DKMS Foundation India under its Access to Transplantation programme.

    High resolution HLA typing is a critical first step in identifying compatible donors for stem cell transplantation, currently the only curative option for many children affected by thalassemia. The collected samples will be processed at the DKMS Life Science Lab in Germany at no cost to participating families. Results are expected within six to eight weeks and will guide transplant related decisions.
    Dr Deenadayalan Munirathnam, Paediatric Transplant Specialist at MGM Cancer Institute, said thalassemia continues to affect thousands of children annually and early transplantation significantly improves outcomes. He said expanding access to donor matching through community level interventions helps bridge financial and logistical barriers that often delay treatment.

    Sarath Babu Voggu, Founder and Chairman of Saptha Foundation, said structured outreach combined with counselling and testing access enables families from lower awareness regions to enter the transplant pathway with clarity. He noted that partnerships with specialised institutions strengthen regional thalassemia response efforts.
    Patrick Paul, Executive Chairman of DKMS Foundation India, said the organisation continues to work with hospitals and non profit partners to extend advanced testing facilities to remote areas. He said the objective is to ensure children requiring transplantation are not restricted by geography or affordability.

    DKMS Foundation India has registered more than 200,000 blood stem cell donors and has facilitated over 200 transplants, supporting patients diagnosed with blood cancers and inherited blood disorders.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • Rising Pet Ownership in Emerging Cities Drives Allpets’ Clinic & Beyond Platform

    Dr. Jasleen Kaur, Founder and Chief Veterinarian, Allpets, and M. Thirumalai, Co-Founder, Allpets, outline a national rollout strategy beginning with the Banjara Hills flagship in Hyderabad

    Hyderabad, 12 February 2026: Growth in pet ownership across India’s emerging cities is reshaping demand for structured veterinary infrastructure, as Allpets unveiled its flagship ‘Clinic & Beyond’ facility in Banjara Hills, Hyderabad.
    The new centre marks a strategic shift toward building an organised, scalable pet healthcare model designed to extend beyond metro markets into Tier 2 and Tier 3 cities. Positioned as an integrated veterinary hub, the facility brings together advanced diagnostics, 24×7 emergency services, pharmacy, hydrotherapy, grooming, boarding, and dedicated wings for cats and exotic pets under a unified operating framework.

    The launch event was headlined by actor Jagapathi Babu, who addressed attendees on the evolving role of pets within Indian households and the growing need for accessible and modern veterinary care systems.
    Founded by Dr. Jasleen Kaur a decade ago, Allpets began as a single clinic and has since expanded into a platform serving more than 15,000 pet parents, conducting over 57,000 consultations and performing more than 1,000 surgeries. The Hyderabad flagship represents the next phase of its development, with infrastructure built to standardise clinical delivery and support future expansion.

    Dr. Jasleen Kaur, Founder and Chief Veterinarian, Allpets, said the flagship reflects the direction veterinary care in India must take, noting that demand for advanced diagnostics, structured clinical systems, and operational discipline has grown significantly over the past decade. She added that the platform is designed to extend specialist-grade care to markets that have historically lacked organised veterinary ecosystems.
    M. Thirumalai, Co-Founder, Allpets, said non-metro India represents the next major growth engine for pet healthcare. He stated that scaling into these regions requires consistent systems, specialist access, and technology-enabled workflows that move beyond fragmented single-practitioner models.

    The Banjara Hills centre houses in-house digital X-ray, ultrasound, ECG, advanced pathology services, hydrotherapy facilities, and specialised treatment areas. With expansion plans targeting cities including Vizag, Coimbatore, Hubli, Nagpur, Surat, Bhubaneshwar, and Patna, Allpets is positioning the Hyderabad facility as the template for a broader national network.
    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

  • OMR Corridor Sees Structured Senior Living Addition from Antara

    Ishaan Khanna, Chief Executive Officer, Antara Assisted Care Services, links the 72 bed facility to Tamil Nadu’s 14 percent senior population and rising elderly isolation

    Senior care infrastructure in Chennai’s Old Mahabalipuram Road corridor has expanded with Antara Senior Care establishing a 72 bed assisted living facility in the city. The development marks the organisation’s second care home in Chennai, complementing its existing presence along East Coast Road.
    Tamil Nadu currently has nearly 14 percent of its population aged 60 and above, making it one of the states with the highest proportion of senior citizens in India. In urban centres, one in seven residents is a senior citizen, and a significant share live alone or only with a spouse. The state also records 6.8 percent of seniors living independently, compared to the national average of 3.6 percent.

    The new facility is designed to provide both short-term and long-term assisted living services. It integrates clinical supervision with daily living support, including housekeeping, laundry, and nutritionally planned meals. Staff members are trained under geriatric care modules approved by the Government of India’s Healthcare Sector Skills Council.
    The care home incorporates ageing-friendly infrastructure such as ramps, wide corridors, grab rails, anti-skid flooring, panic buttons, and open terraces. Suite-style rooms accommodate both single and couple occupancy and connect to shared common areas intended to encourage interaction. Each floor includes a nurses’ station, supported by an in-house clinic and physiotherapy room to address evolving medical needs.

    Commenting on the development, Ishaan Khanna, Chief Executive Officer, Antara Assisted Care Services, said Tamil Nadu’s ageing profile is advancing more rapidly than many other states. He noted that higher levels of elderly isolation and a growing number of post-acute patients requiring structured long-term care have increased demand for organised assisted living environments within the city.
    The OMR facility extends Antara’s assisted living footprint in Chennai, reflecting the broader need for specialised senior care infrastructure in urban India.

    At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.